Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely

Ayelet Grupper*, Helena Katchman

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

23 Scopus citations
Original languageEnglish
Pages (from-to)2909
Number of pages1
JournalAmerican Journal of Transplantation
Volume21
Issue number8
DOIs
StatePublished - Aug 2021

Keywords

  • clinical research / practice
  • complication: infectious
  • infectious disease
  • kidney transplantation / nephrology
  • vaccine

Cite this